I have assessed patients referred to me with a working diagnosis of adult acne who had not responded to any standard acne treatment. Several had uniform inflammatory papulopustules in a central facial distribution, no comedones at all, persistent central facial flushing, and a history of failed antibiotic courses for skin that was being managed as acne. They did not have acne. They had papulopustular rosacea with elevated Demodex activity. Once referred and treated appropriately, their skin responded. The misclassification had cost them months.
Demodex folliculorum is part of that clinical picture. It is not widely discussed in aesthetic practice, but it belongs in the consultation framework for any practitioner seeing patients with inflammatory facial presentations.
What Demodex Folliculorum Is
Demodex folliculorum is a mite. It lives in sebaceous follicles and is a normal part of the skin microbiome in low numbers. It is present in most adult human skin and at low density causes no visible reaction. The mite feeds on sebum and follicular epithelial cells.
In patients with rosacea, particularly the papulopustular subtype, mite density is significantly higher than in the general population. The mechanism connecting elevated Demodex density to clinical rosacea involves innate immune activation. Mite by-products, including bacterial components from organisms that colonise Demodex, trigger overproduction of the antimicrobial peptide LL-37, which in rosacea-prone skin drives vascular dilation, immune cell recruitment, and the inflammatory cycle that produces papulopustular lesions.
The NICE Clinical Knowledge Summary on rosacea identifies Demodex infestation as a contributing factor in papulopustular rosacea and lists ivermectin 1% cream as a recommended treatment option. That prescription sits outside the scope of aesthetic practice. Understanding the mechanism and recognising the presentation does not.
How Papulopustular Rosacea with Elevated Demodex Presents
There are specific clinical features to look for when Demodex is likely contributing to the presentation.
Lesions are inflammatory papulopustules, typically 3 to 4mm, with a uniform and consistent appearance across the affected area. There are no comedones. The absence of blackheads and whiteheads is the critical differentiating feature from acne vulgaris, where comedonal activity is almost always present. A patient presenting with inflammatory lesions and no comedones needs rosacea considered before acne management continues.
The distribution is central: cheeks, nose, chin, and forehead. Background erythema and persistent flushing in the same region are usually present. Patients often report that their skin is consistently reactive to temperature change, alcohol, and spicy foods.
The treatment history is often telling. Many patients with this presentation have tried acne protocols including topical retinoids and benzoyl peroxide with limited improvement or worsened reactivity. That history, combined with the clinical features above, points firmly away from acne and toward a rosacea subtype requiring different management.
The Barrier Connection
Barrier impairment in rosacea skin, documented in BAD guidelines and consistent across the published evidence, creates the conditions in which Demodex colonisation increases. An impaired epidermal barrier allows increased follicular penetration. It also reduces the skin's capacity to regulate the innate immune response that Demodex activity triggers.
This is why barrier support remains a clinical priority across all rosacea subtypes, including papulopustular presentations. It is not separate from the Demodex question. It is the structural context in which Demodex activity becomes clinically significant. Reduced ceramide levels, elevated transepidermal water loss, and disrupted tight junction proteins all amplify the inflammatory response to mite by-products in susceptible skin.
A barrier-first approach has mechanistic justification here, not just for maintenance between treatments but as the foundation before any other clinical step is introduced.
What Aesthetic Practitioners Can Do
Outside prescribing scope, the aesthetic practitioner's role where papulopustular rosacea with suspected Demodex involvement is clear: refer accurately, support the barrier, and avoid compounding the problem.
Refer to the GP for formal diagnosis and access to ivermectin cream if appropriate. The referral letter should document the inflammatory distribution, the absent comedones, the treatment history with acne protocols, and the flushing pattern. A clear referral saves the GP time and gets the patient to the right treatment sooner than a vague "not responding to acne treatment."
In the meantime, barrier-supportive skincare applies here as it does across all rosacea presentations. Ceramide-containing moisturisers, fragrance-free formulations, pH-appropriate gentle cleansers. Reducing the barrier's vulnerability reduces the severity of the inflammatory response, even while waiting for the prescriber's assessment.
Avoid treatments that heat the skin, physically disrupt the follicle, or rely on strong actives. These worsen the inflammatory cycle in sensitised rosacea skin regardless of the Demodex contribution.
When to Refer
Refer to the GP when:
- Inflammatory papulopustules are present without comedones
- Central facial distribution and background erythema fit rosacea rather than acne
- Standard acne protocols have produced no improvement or have worsened reactivity
- The patient reports persistent flushing linked to temperature, alcohol, or specific foods
A referral in these cases is not a clinical failure. It is accurate assessment acted on correctly. Patients with papulopustular rosacea who have been managed as acne for months need the correct diagnosis more than they need another topical retinoid.
Identifying that distinction at consultation is precisely the clinical skill that protects patients and defines the quality of the practitioner.
For practitioners who want the full clinical framework for rosacea, covering subtypes, barrier pathophysiology, Demodex, treatment sequencing, and the consultation model that supports long-term outcomes, Rosacea Beyond Redness covers the condition at the depth that aesthetic practice requires. Available now at aestheticsunlocked.co.uk.